EMEA-002938-PIP01-20 - paediatric investigation plan

Islatravir

Key facts

• Active substance:
  Islatravir
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/0407/2021
• PIP number:
  EMEA-002938-PIP01-20
• Pharmaceutical form(s):
  Tablet
• Condition(s) / indication(s):
  Prevention of human immunodeficiency virus (HIV-1) infection
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  08/10/2021
• Compliance check done:
  No

Decision

P/0407/2021 : EMA decision of 8 October 2021 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for islatravir (EMEA-002938-PIP01-20)

Adopted Reference Number: EMA/549068/2021